Beyond ICD codes: Unlocking rare disease insights with genomics and claims-based data

Rare disease research begins with understanding the underlying biology. GeneDx Infinity - the world's largest clinically interpreted rare disease database - combines clinically generated genomic data and expert interpretation to help biopharma identify the right patients and better understand disease biology. When linked with Komodo Health's longitudinal claims-based data, researchers gain a more complete view of the patient journey, connecting genetic insights to treatment patterns, healthcare utilization, and long-term outcomes.

Join experts from GeneDx and Komodo Health to explore how integrated genomic and claims-based data can improve patient finding, enable more precise rare disease cohorts, and generate higher-confidence real-world evidence across the drug development lifecycle. The session will also demonstrate how GeneDx Infinity and Komodo's AI-first capabilities, including Marmot, help transform complex datasets into actionable insights for discovery, clinical development, and post-launch evidence generation.